期刊文献+

0.33%罗哌卡因用于乳腺癌根治术的临床观察 被引量:2

The Clinical Observation of 0.33% Ropivacaine for Radical Mastectomy
下载PDF
导出
摘要 目的:比较0.33%罗哌卡因与1%利多卡因高位硬膜外麻醉用于乳腺癌手术的临床效果和安全性。方法:选择40例ASA I-Ⅱ级择期乳腺癌手术患者,随机分为两组,行T3-4间隙穿刺置管。I组注入0.33%罗哌卡因,Ⅱ组注入1%利多卡因。观察比较两组麻醉阻滞前、阻滞后10、20、30min时HR、SBP、DBP、SpO2及VC、FVC、FEV1、MVV各参数的变化;比较两组麻醉起效时间、麻醉阻滞范围及麻醉效果。结果:①两组阻滞后10、20、30min时,HR均较阻滞前明显减慢(P<0.05)、SBP、DBP及SpO2组间比较差异无统计学意义(P>0.O5);②两组肺通气功能指标均有下降,但Ⅱ组各项指标下降幅度较I组明显,差异有显著性(P<0.05);③两组患者在麻醉起效时间、阻滞范围及麻醉效果比较差异无显著性(P>0.05)。结论:0.33%盐酸罗哌卡因高位硬膜外麻醉在乳腺癌根治术中比1%利多卡因对肺通气功能的影响更轻微。 Objective: Comparing the clinical efficacy and safety of 0.33% ropivacaine and 1% lidocaine epidural anesthesia for breast surgery.Method: Selected the 40 cases of ASA I^II elective breast cancer surgery randomly divided into two groups,all the patients were given T_3-4 space catheterization.Group I was injected 0.33% ropivacaine,the other group was injected 1% lidocaine.Comparison the two groups before anesthesia block,block after 10,20,30min while HR,SBP,DBP,SpO_2 and VC,FVC,FEV1,MVV changes in the parameters.The onset time of anesthesis,the range and anesthesis block were also compared. Result: ①When blocked the two groups after 10,20,30 min,HR was significantly slower than block(P0.05),but SBP,DBP and SpO_2 between groups was not statistically significant(P0.05).②The two sets of indicators have decreased pulmonary function,however,the indicators of groups II decreased significantly compared with group I,the difference was significant(P0.05).③The two groups of patients in the anesthesia onset time,block scope and effect of anesthesia was no significant difference(P0.05).Conclusion: 0.33% ropivacaine hydrochloride epidural anesthesia in radical mastectomy is better than 1% lidocaine towards the pulmonary function.
出处 《河北医学》 CAS 2012年第2期202-205,共4页 Hebei Medicine
关键词 乳腺癌 罗哌卡因 利多卡因 硬膜外阻滞 Breast cancer Ropivacaine Lidocaine Epidural
  • 相关文献

参考文献6

二级参考文献17

  • 1BRODRUIK P M, WEBSTER N R, NUNN J F. The laryngeal mask airway. A study of 100 patients during spontaneous breathing [J] .Anaesthesia, 1989, 44(4): 238 - 241. 被引量:1
  • 2HUNT-SMITH J, DONAGHY A, LESLIE K, et al. Safety and efficacy of target coutrolled infusion (Diprifusor) vs manuallg controlled infusion of profofol for anaesthosia [J]. Auaesth Intencicve Care, 1999, 27 (3) : 206 - 264. 被引量:1
  • 3安刚 薛富善 主编.现代麻醉学技术[M].北京:科学技术文献出版社,2001.8. 被引量:109
  • 4Lee A,Fagan D,Lamont M,Tucker GT,Halldin M,Scott DB.Disposition kinetics of ropivacaine in humans[].Anesthesia and Analgesia.1989 被引量:1
  • 5Ekstrom G,Gunnarsson UB.Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P-450 1A and 3A in human liver microsomes[].Drug Metabolism and Disposition.1996 被引量:1
  • 6Valenzuela C,Delpon E,Franqueza L,Gay P,Snyders DJ,Tamargo J.Effects of ropivacaine on a potassium channel (hKv 1. 5) cloned from human ventricle[].Anesthesiology.1997 被引量:1
  • 7Hirota K,Browne T,Appadu BL,Lambert DG.Do local anaesthetics interact with dihydropyridine binding sites on neuronal Ltype Ca+ channels?[].British Journal of Anaesthesia.1997 被引量:1
  • 8Reiz S,Haggmark S,Johansson G,Nath S.Cardiotoxicity of ropivacaine———A new amide local anaesthetic agent[].Acta Anaesthesiologica.1989 被引量:1
  • 9Feldman HS,Arthur GR,Covino BG.Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog[].Anesthesia and Analgesia.1989 被引量:1
  • 10Nancarrow C,Rutten AJ,Runciman WG,et al.Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep[].Anesthesia and Analgesia.1989 被引量:1

共引文献77

同被引文献23

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部